Cardiol Therapeutics Inc. — Form D

Cardiol Therapeutics Inc. of OAKVILLE, A6, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-04. The offering totals $8.4M, of which $3.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Deborah E BrownDirectorOakville, A6
Iain E ChalmersDirectorOakville, A6
Terry E LynchDirectorOakville, A6
Peter E PekosDirectorOakville, A6
Guillermo E Torre-AmioneDirectorOakville, A6
Anthony E BoltonExecutive OfficerOakville, A6
Anthony E BoltonPromoterOakville, A6
Guillermo Torre-AmioneDirectorOakville, A6
David ElsleyDirectorOakville, A6
David ElsleyExecutive OfficerOakville, A6
David ElsleyPromoterOakville, A6
Chris WaddickDirectorOakville, A6
Chris WaddickExecutive OfficerOakville, A6
Teri LoxamDirectorOakville, A6
Jennifer ChaoDirectorOakville, A6
Bernard LimExecutive OfficerOakville, A6
Peter PekosDirectorOakville, A6
Colin StottDirectorOakville, A6
Andrew HamerExecutive OfficerOakville, A6
Tim GarnettDirectorOakville, A6
Deborah R BrownDirectorOakville, A6
Colin R StottDirectorOakville, A6
Eldon R SmithDirectorOakville, A6
Eldon R SmithExecutive OfficerOakville, A6
Eldon R SmithPromoterOakville, A6

Other filings by this issuer (4)

FiledFormOfferingSold
2025-11-04D$8.5M$760K
2020-12-15D$9.1M$829K
2017-09-29D$680K$680K
2017-03-29D$56K$56K

More